Navigation Links
Surgical Care Affiliates Names New SVP for Special Projects
Date:10/18/2007

BIRMINGHAM, Ala., Oct. 18 /PRNewswire/ -- Surgical Care Affiliates (SCA) has named Ali Reza as its senior vice president of special projects. Mr. Reza will be responsible for a variety of ongoing initiatives and projects as the company positions itself for future growth.

"We are pleased to bring someone with Ali's experience to this important role," said SCA President and CEO Mike Snow. "His previous work in the areas of operational turnaround and strategic planning in the health care industry will be a valuable asset as we move forward - he will be a great addition to our leadership team."

Prior to joining SCA, Mr. Reza was a principal with the Boston Consulting Group, an international strategy and general management consulting firm, where he served as a core member of the group's healthcare practice area and worked on a variety of projects in the United States, Europe, and Asia. Mr. Reza's functional focus for his clients was on operational turnaround, post-merger integration, and sales force effectiveness.

Mr. Reza received a bachelor's degree in international relations from Tufts University and a master's degree in business administration from the Wharton School at the University of Pennsylvania.

About Surgical Care Affiliates

Surgical Care Affiliates (SCA), with its affiliated physicians and partners, is committed to delivering high quality surgical services to ensure a superior patient experience and clinical outcome. One of the largest providers of specialty surgical services, SCA operates approximately 140 ambulatory surgery centers and surgical hospitals across the country with 6,000 employees and more than 3,000 physician partners. For more information on SCA, visit http://www.scasurgery.com.


'/>"/>
SOURCE Surgical Care Affiliates
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. Indonesian boy with huge neck tumor was surgically removed
2. New spray gel heals surgical wounds
3. FDA approves surgical gel
4. Lower surgical volume linked to higher death rate
5. Sleep apnoea linked to surgical risks
6. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
7. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
8. Surgeon Attempts to Create A Surgical Hernia Feat
9. Researchers Aim To Develop Next Generation Of Surgical Robots
10. Arrow Embedded In Tribal’s Chest For Two Weeks Surgically Remove
11. Surgical Intervention to Solve Obesity and Related Problems
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Sundia MediTech Appoints Dr Chen Chen as Senior VP of Chemistry 50700 1Sundia MediTech Appoints Dr Chen Chen as Senior VP of Chemistry 50700 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 1Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 2Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 3Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 50697 4Dr Julian Whitaker Featured on Searchjointpain com 50694 1Dr Julian Whitaker Featured on Searchjointpain com 50694 2